Market Cap : 161.36 B | Enterprise Value : 191.14 B | PE Ratio : 25.11 | PB Ratio : 4.95 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2022-08-14), Bristol-Myers Squibb Co's share price is $75.57. Bristol-Myers Squibb Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was $6.99. Hence, Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow Ratio for today is 10.81.
The historical rank and industry rank for Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Bristol-Myers Squibb Co's highest Price-to-Operating-Cash-Flow Ratio was 97.02. The lowest was 6.93. And the median was 12.89.
BMY's Price-to-Operating-Cash-Flow is ranked better thanBristol-Myers Squibb Co's Cash Flow from Operations per share for the three months ended in Jun. 2022 was $1.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was $6.99.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bristol-Myers Squibb Co was 26.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 29.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.90% per year.
During the past 13 years, Bristol-Myers Squibb Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.00% per year. The lowest was -39.20% per year. And the median was 14.45% per year.
The historical data trend for Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow falls into.
Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 75.57 | / | 6.989 | |
= | 10.81 |
Bristol-Myers Squibb Co's Share Price of today is $75.57.
Bristol-Myers Squibb Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.99.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Greenlees Sharon | officer: SVP & Controller | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Meyers Gregory Scott | officer: EVP, Chief Digital & Tech Off. | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Weese Michelle | officer: EVP, Corporate Affairs | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Hidalgo Medina Manuel | director | BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016 |
Rice Derica W | director | 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Mily Elizabeth | officer: EVP, Strategy & BD | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540 |
Metcalfe Kathryn | officer: EVP, Corporate Affairs | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Vessey Rupert | officer: Pres., Research & Early Dev. | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Elkins David V | officer: EVP, Chief Financial Officer | C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Yale Phyllis R | director | |
Ahmed Nadim | officer: President, Hematology | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Other Sources
By Zacks 2022-03-16
By Zacks 2022-03-16
By Zacks 2022-04-04
By Zacks 2022-03-28
By Zacks 2022-04-05
By Zacks 2022-03-21
By Fool 2022-03-29
By tipranks.com 2022-03-21
By Fool 2022-03-30
By Zacks 2022-03-30
By Zacks 2022-03-29
By Zacks 2022-03-21
By Fool 2022-03-31
By Zacks 2022-03-16